Literature DB >> 3588899

Idiopathic varicoceles: feasibility of percutaneous sclerotherapy.

G Sigmund, W Bähren, H Gall, M Lenz, W Thon.   

Abstract

Percutaneous retrograde venography was performed in 717 patients with a left-sided idiopathic varicocele. In 674 (94.0%), testicular (internal spermatic) vein insufficiency was proved by contrast medium reflux from the left renal vein into the testicular vein, down to the pampiniform plexus. The different venographic patterns of the testicular veins were classified into seven basic types. Five of these, comprising 624 patients, had incompetent or missing valves all along the trunk of the testicular vein. In 554 of the 624 (88.8%), sclerotherapy was performed, but such treatment was possible in only three of 50 patients with a competent orifice valve bypassed by an insufficient collateral (type IVb). In 43 of the 717 patients (6.0%), no insufficient vein could be found at all (type 0). The mean fluoroscopy time was 4.4 minutes. There were no serious complications associated with venography or sclerotherapy, and the initial recurrence rate was 9.8%. Percutaneous sclerotherapy is therefore a simple, safe, and effective treatment of testicular vein insufficiency and is suitable for almost 80% of patients with varicoceles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3588899     DOI: 10.1148/radiology.164.1.3588899

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Embolization of the internal spermatic vein in varicocele: significance of venous pressure.

Authors:  S H Kim; J H Park; M C Han; J S Paick
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Mar-Apr       Impact factor: 2.740

2.  Long-term results of microsurgical drainage for idiopathic varicocele.

Authors:  G Flati; C Talarico; D Flati; M La Pinta; B Porowska; D Proposito; M Carboni
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

3.  A simple ultrasonographic test for preoperative haemodynamic evaluation of varicocele.

Authors:  G Flati; D Flati; M La Pinta; B Porowska; C Talarico; M Carboni
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 4.  Varicocele: A Review.

Authors:  Brian F Baigorri; Robert G Dixon
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

5.  Left spermatic vein retrograde sclerosis: comparison between sclerosant agent injection through a diagnostic catheter versus through an occluding balloon catheter.

Authors:  Antonio Basile; Giovanni Failla; Sandro La Vignera; Rosita Angela Condorelli; Aldo Calogero; Enzo Vicari; Antonio Granata; Elena Mundo; Giuseppe Caltabiano; Marco Pizzarelli; Martina Messina; Giovanni Scavone; Franz Lanzafame; Roberto Iezzi; Dimitrios Tsetis
Journal:  Radiol Med       Date:  2014-12-02       Impact factor: 3.469

6.  Gonadal vein embolization: treatment of varicocele and pelvic congestion syndrome.

Authors:  Mark A Bittles; Eric K Hoffer
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

7.  Percutaneous retrograde varicocele embolisation using tungsten embolisation coils: a five year audit.

Authors:  S R Keoghane; L Jones; M P Wright; J Kabala
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

8.  Varicocele percutaneous embolization outcomes in a pediatric group: 7-year retrospective study.

Authors:  Sonaz Malekzadeh; Rodrigo A Fraga-Silva; Pierre-Henri Morère; Alexandra Sorega; Stephan Produit; Nikolaos Stergiopulos; Christophe Constantin
Journal:  Int Urol Nephrol       Date:  2016-06-30       Impact factor: 2.370

9.  Retrograde percutaneous sclerotherapy of left idiopathic varicocele in children: results and follow-up.

Authors:  Claudio Granata; Mauro Oddone; Paolo Toma; Girolamo Mattioli
Journal:  Pediatr Surg Int       Date:  2008-03-26       Impact factor: 1.827

Review 10.  Recurrent varicocele.

Authors:  Katherine Rotker; Mark Sigman
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.